JNK-IN-8: a novel covalent inhibitor targeting JNK signaling in triple-negative breast cancer

被引：0
|
作者：
Xie, Xuemei [1 ]
Kaoud, Tamer S. [2 ]
Edupunganti, Ramakrishna [2 ]
Zhang, Tinghu [3 ]
Kogawa, Takahiro [1 ]
Chauhan, Gaurav B. [1 ]
Gray, Nathanael S. [3 ]
Bartholomeusz, Chandra [1 ]
Dalby, Kevin N. [2 ]
Ueno, Naoto T. [1 ]
机构：
[1] UT MD Anderson Canc Ctr, Houston, TX USA
[2] Univ Texas Austin, Austin, TX 78712 USA
[3] Harvard Univ, Sch Med, Boston, MA USA
来源：
CANCER RESEARCH | 2014年 / 74卷 / 19期
关键词：
D O I：
10.1158/1538-7445.AM2014-750
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
750
引用
收藏
页数：2
相关论文
共 50 条
  • [31] Targeting Cancer Stem Cells in Triple-Negative Breast Cancer
    Park, So-Yeon
    Choi, Jang-Hyun
    Nam, Jeong-Seok
    CANCERS, 2019, 11 (07)
  • [32] Targeting Notch signaling in cancer stem-like cells of triple-negative breast cancer
    Murphy, Adrienne M.
    Ucar, Ayse D.
    Miele, Lucio
    CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION, 2022, 31 (01)
  • [33] Overexpression of BIRC6 driven by EGF-JNK-HECTD1 signaling is a potential therapeutic target for triple-negative breast cancer
    Li, Yongpeng
    Tan, Yanan
    Wen, Lijuan
    Xing, Zhihao
    Wang, Changxu
    Zhang, Liuhui
    Wu, Kai
    Sun, Haiyan
    Li, Yuqing
    Lei, Qifang
    Wu, Song
    MOLECULAR THERAPY-NUCLEIC ACIDS, 2021, 26 : 798 - 812
  • [34] CFLAR targeting selectively exploits extrinsic apoptosis signaling in triple-negative breast cancer
    Quereda, Victor
    O'Brien, Shane W.
    Della Pietra, Tony C.
    Foley, James J.
    Fedoriw, Andy
    MOLECULAR CANCER THERAPEUTICS, 2024, 23 (06)
  • [35] Effects of Metformin on JNK Signaling Pathway and PD-L1 Expression in Triple Negative Breast Cancer
    Wang, Ruibin
    Zhao, Yanjie
    CANCER MANAGEMENT AND RESEARCH, 2024, 16 : 259 - 268
  • [36] Anti-proliferation of triple-negative breast cancer cells with physagulide P: ROS/JNK signaling pathway induces apoptosis and autophagic cell death
    Yu, Pei
    Zhang, Chao
    Gao, Cai-Yun
    Ma, Ting
    Zhang, Hao
    Zhou, Miao-Miao
    Yang, Yan-Wei
    Yang, Lei
    Kong, Ling-Yi
    ONCOTARGET, 2017, 8 (38) : 64032 - 64049
  • [37] Novel combinatorial Therapeutics targeting cancer epigenetics and metabolism in human triple-negative breast cancer
    Natesh, J.
    Penta, D.
    Mondal, P.
    Somashekar, B. S.
    Meeran, S. M.
    CANCER MEDICINE, 2018, 7 : 40 - 41
  • [38] Elevated STC-1 augments the invasiveness of triple-negative breast cancer cells through activation of the JNK/c-Jun signaling pathway
    Han, Jeonghun
    Jeon, Myeongjin
    Shin, Incheol
    Kim, Sangmin
    ONCOLOGY REPORTS, 2016, 36 (03) : 1764 - 1771
  • [39] The transcriptional coactivator WBP2 primes triple-negative breast cancer cells for responses to Wnt signaling via the JNK/Jun kinase pathway
    Li, Zilin
    Lim, Shen Kiat
    Liang, Xu
    Lim, Yoon Pin
    JOURNAL OF BIOLOGICAL CHEMISTRY, 2018, 293 (52) : 20014 - 20028
  • [40] Targeting MET and EGFR crosstalk signaling in triple-negative breast cancers
    Linklater, Erik S.
    Tovar, Elizabeth A.
    Essenburg, Curt J.
    Turner, Lisa
    Madaj, Zachary
    Winn, Mary E.
    Melnik, Marianne K.
    Korkaya, Hasan
    Maroun, Christiane R.
    Christensen, James G.
    Steensma, Matthew R.
    Boerner, Julie L.
    Graveel, Carrie R.
    ONCOTARGET, 2016, 7 (43) : 69903 - 69915
12345